(Q46753306)

24 December 2017

title

A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir (English)

1 reference

24 December 2017

0 references

Caspary F

1

1 reference

24 December 2017

Elliott G

2

1 reference

24 December 2017

Navé BT

3

1 reference

24 December 2017

Verzaal P

4

1 reference

24 December 2017

Rohrbach M

5

1 reference

24 December 2017

Das PK

6

1 reference

24 December 2017

Nagelkerken L

7

1 reference

24 December 2017

Nieland JD

8

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

24 December 2017

British Journal of Dermatology

published in

1 reference

24 December 2017

volume

153

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

937-944

1 reference

24 December 2017

The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

The keratinocyte as a target for staphylococcal bacterial toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Psoriasis is a visible manifestation of the skin's defense against micro-organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Animal models of psoriasis - what can we learn from them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Polyunsaturated fatty acids and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

NSAIDs in dermatologic therapy: review and preview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

n-3 fatty acids in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06811.X

10.1111/J.1365-2133.2005.06811.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017